341 related articles for article (PubMed ID: 18394814)
1. Comparison of FDG-PET/CT and CT for delineation of lumpectomy cavity for partial breast irradiation.
Ford EC; Lavely WC; Frassica DA; Myers LT; Asrari F; Wahl RL; Zellars RC
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):595-602. PubMed ID: 18394814
[TBL] [Abstract][Full Text] [Related]
2. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
[TBL] [Abstract][Full Text] [Related]
3. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
4. Primary tumor delineation based on (18)FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy.
Leclerc M; Lartigau E; Lacornerie T; Daisne JF; Kramar A; Grégoire V
Radiother Oncol; 2015 Jul; 116(1):87-93. PubMed ID: 26088157
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of Lumpectomy Cavity Delineations Between Use of Magnetic Resonance Imaging and Computed Tomography Acquired With Patient in Prone Position for Radiation Therapy Planning of Breast Cancer.
Huang W; Currey A; Chen X; Li B; Bergom C; Kelly T; Wilson JF; Li XA
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):832-40. PubMed ID: 26972656
[TBL] [Abstract][Full Text] [Related]
6. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
[TBL] [Abstract][Full Text] [Related]
7. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.
Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143
[TBL] [Abstract][Full Text] [Related]
9. Influence of FDG-PET on computed tomography-based radiotherapy planning for locally recurrent nasopharyngeal carcinoma.
Zheng XK; Chen LH; Wang QS; Wu HB; Wang HM; Chen YQ; Yan WP; Li QS; Xu YK
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1381-8. PubMed ID: 17869450
[TBL] [Abstract][Full Text] [Related]
10. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques.
Weed DW; Edmundson GK; Vicini FA; Chen PY; Martinez AA
Brachytherapy; 2005; 4(2):121-9. PubMed ID: 15893265
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
Vinod SK; Kumar S; Holloway LC; Shafiq J
J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
[TBL] [Abstract][Full Text] [Related]
12. The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: a prospective study.
Mah K; Caldwell CB; Ung YC; Danjoux CE; Balogh JM; Ganguli SN; Ehrlich LE; Tirona R
Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):339-50. PubMed ID: 11872279
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric comparison of conventional radiograph- and three-dimensional computed tomography-based planning using dose volume indices for partial breast intraoperative implants.
Sharma SD; Budrukkar A; Upreti RR; Munshi A; Jalali R; Deshpande DD
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):46-52. PubMed ID: 18029158
[TBL] [Abstract][Full Text] [Related]
14. Defining the target in cancer of the oesophagus: direct radiotherapy planning with fluorodeoxyglucose positron emission tomography-computed tomography.
le Grange F; Wickers S; Warry A; Warrilow J; Bomanji J; Tobias JS
Clin Oncol (R Coll Radiol); 2015 Mar; 27(3):160-7. PubMed ID: 25540907
[TBL] [Abstract][Full Text] [Related]
15. 3D CT-based high-dose-rate breast brachytherapy implants: treatment planning and quality assurance.
Das RK; Patel R; Shah H; Odau H; Kuske RR
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1224-8. PubMed ID: 15234059
[TBL] [Abstract][Full Text] [Related]
16. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluorodeoxyglucose positron emisson tomography/computed tomography guided conformal brachytherapy for cervical cancer.
Nam H; Huh SJ; Ju SG; Park W; Lee JE; Choi JY; Kim BT; Kim CK; Park BK
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):e29-34. PubMed ID: 22503526
[TBL] [Abstract][Full Text] [Related]
18. [The use of PET/CT in radiotherapy of patients with non-small cell lung cancer].
Lõcsei Z; Hideghéty K; Farkas R; Bellyei S; Sárosi V; Sebestyén K; Sebestyén Z; Kovács P; Mangel L
Magy Onkol; 2011 Nov; 55(4):274-80. PubMed ID: 22128310
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
[TBL] [Abstract][Full Text] [Related]
20. Customized computed tomography-based boost volumes in breast-conserving therapy: use of three-dimensional histologic information for clinical target volume margins.
Hanbeukers B; Borger J; van den Ende P; van der Ent F; Houben R; Jager J; Keymeulen K; Murrer L; Sastrowijoto S; van de Vijver K; Boersma L
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):757-63. PubMed ID: 19304402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
